Term ends no later than Sep 24, 2031 · Medium confidence
20-year base term ends Jul 11, 2031
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Jul 11, 2011
Sep 24, 2031
Jan 12, 2016
This patent's term runs 75 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 11, 2011, when application PCT/US2011/043569, the earliest non-provisional in its chain, was filed (this one was filed Mar 11, 2013) | Jul 11, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +75 days, USPTO patent term adjustment record | Sep 24, 2031 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Sep 24, 2031 | Medium confidence |
This family
| Application PCT/US2011/043569 | PCT application no patent term | no patent term |
| US 9,233,145 | this patent no later than Sep 2031 | no later than Sep 2031 |
| US 9,670,475 | In force Jul 2031 | Jul 2031 |
| US 9,867,873 | In force Jul 2031 | Jul 2031 |
| US 9,675,676 | In force Jul 2031 | Jul 2031 |
| US 9,623,091 | In force Jul 2031 | Jul 2031 |
| US 9,629,903 | In force Jul 2031 | Jul 2031 |
| Application 15/820,080 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 6, 2013 Reel 31730, frame 427 | Pierce, Glenn; Truex, Samantha; Peters, Robert T.; Jiang, Haiyan | Biogen Idec Hemophilia Inc. | Assignment of Assignor's Interest |
| Apr 30, 2015 Reel 35553, frame 325 | Biogen Idec Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Name |
| Jul 2, 2015 Reel 36051, frame 773 | Biogen Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Address |
| Feb 16, 2017 Reel 41735, frame 703 | Biogen Hemophilia Inc. | Bioverativ Therapeutics Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Sep 24, 2031. We will not guess the cap.